deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT04618523

Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo (TET2020)

Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Democratic Republic of the Congo: a Randomized Controlled Trial

Sponsor: Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

Conditions Malaria
Interventions Artemether-lumefantrine Artesunate-amodiaquine
Updated 10 times since 2020 Last updated: Feb 8, 2022 Started: Oct 26, 2020 Primary completion: Feb 8, 2022 Completion: Feb 8, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04618523, this PHASE4 trial focuses on Malaria and remains completed. Sponsored by Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo, it has been updated 10 times since 2020, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotNot Yet Recruiting~Apr 2021 – ~Jun 2021 · 2 months · monthly snapshotRecruiting~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshotRecruiting~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshotRecruiting~Dec 2021 – ~Mar 2022 · 3 months · monthly snapshotRecruiting~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Mar 2022 — Jul 2024 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  5. Dec 2021 — Mar 2022 [monthly]

    Recruiting PHASE4

▶ Show 5 earlier versions

  1. Sep 2021 — Dec 2021 [monthly]

    Recruiting PHASE4

  2. Jun 2021 — Sep 2021 [monthly]

    Recruiting PHASE4

  3. Apr 2021 — Jun 2021 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  4. Jan 2021 — Apr 2021 [monthly]

    Not Yet Recruiting PHASE4

  5. Dec 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Oct 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
  • Ministry of Public Health, Democratic Republic of the Congo
  • University of Kinshasa
  • World Health Organization
Data source: Ministry of Public Health, Democratic Republic of the Congo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations